Terms: = Head and neck cancer AND uPA AND Staging
6 results:
1. Relationships of upa and VEGF expression in esophageal cancer and microvascular density with tumorous invasion and metastasis.
Jiang JT; Zhang LF; Zhou B; Zhang SQ; Li SM; Zhang W; Zhang J; Qiao Z; Kong RR; Ma YF; Chen S
Asian Pac J Cancer Prev; 2012; 13(7):3379-83. PubMed ID: 22994764
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic value analysis of urokinase-type plasminogen activator receptor in oral squamous cell carcinoma: an immunohistochemical study.
Bacchiocchi R; Rubini C; Pierpaoli E; Borghetti G; Procacci P; Nocini PF; Santarelli A; Rocchetti R; Ciavarella D; Lo Muzio L; Fazioli F
BMC Cancer; 2008 Aug; 8():220. PubMed ID: 18673553
[TBL] [Abstract] [Full Text] [Related]
3. Increased levels of urokinase receptor in plasma of head and neck squamous cell carcinoma patients.
Schmidt M; Hoppe F
Acta Otolaryngol; 1999; 119(8):949-53. PubMed ID: 10728940
[TBL] [Abstract] [Full Text] [Related]
4. An orthotopic floor-of-mouth cancer model allows quantification of tumor invasion.
Simon C; Nemechek AJ; Boyd D; O'Malley BW; Goepfert H; Flaitz CM; Hicks MJ
Laryngoscope; 1998 Nov; 108(11 Pt 1):1686-91. PubMed ID: 9818827
[TBL] [Abstract] [Full Text] [Related]
5. Localization of plasminogen activators and their inhibitor in squamous cell carcinomas of the head and neck.
Yasuda T; Sakata Y; Kitamura K; Morita M; Ishida T
Head Neck; 1997 Oct; 19(7):611-6. PubMed ID: 9323150
[TBL] [Abstract] [Full Text] [Related]
6. Measurement of urokinase-type plasminogen activator activity in sera of nasopharyngeal carcinoma patients by an immunocapture assay.
Leung KC; Tung Y; Ali M; Lau WN
Cancer Lett; 1991 Jul; 58(3):233-40. PubMed ID: 1649695
[TBL] [Abstract] [Full Text] [Related]
